COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting
02/05/2018
– Identification of T Cell Immunomodulatory Domain in Resokine – SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of [...]
Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis
02/05/2018
Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical company with a core focus [...]
Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10
02/05/2018
BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, May 10, at 4:30 p.m. ET to [...]
Insmed Reports First Quarter 2018 Financial Results and Provides Business Update
02/05/2018
Submitted NDA to FDA for Amikacin Liposome Inhalation Suspension (ALIS) in NTM lung disease caused by MAC; anticipates priority review Actively preparing for potential product launch of ALIS in 4Q 2018 BRIDGEWATER, N.J [...]
Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018
02/05/2018
DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results
02/05/2018
RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy [...]
Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update
02/05/2018
Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 9, 2018 SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative [...]
Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies
02/05/2018
– Newly issued patent expands protection for tipifarnib in U.S., provides exclusivity in certain CXCL12-expressing cancers to 2037 – – Second U.S. patent for tipifarnib reinforces potential for broader strategy to [...]
Avadel Pharmaceuticals Reports First Quarter 2018 Results
02/05/2018
NOCTIVA™ launch underway across the U.S. FT 218 granted Orphan Drug Designation Generated revenue of $33.3 million DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ) today [...]
PCI Biotech: Invitation to first quarter 2018 presentation
02/05/2018
Oslo,Norway, 2 May 2018 - PCI Biotech invites to a presentation of the company's first quarter 2018 report on Tuesday 8 May 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 8, 08:30am - 09:30am CEST (local [...]
Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers
02/05/2018
SALT LAKE CITY, May 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that the company was named to Forbes 2018 list of [...]
Achaogen Stock Trading Halted Today
02/05/2018
-- FDA Advisory Committee to Review Plazomicin for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) and Bloodstream Infections (BSI) -- SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE [...]
Antares Pharma to Present at the Deutsche Bank Securities, Inc. 43rd Annual Health Care Conference
02/05/2018
EWING, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert Apple, President and Chief Executive Officer, will present at the Deutsche Bank Securities, Inc. 43rd Annual [...]
Rapid Micro Biosystems Secures $60 Million In Equity Financing
02/05/2018
Investment to Accelerate Company's Continued Global Commercial Expansion and Product Innovation LOWELL, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, the leading provider of automated, growth-based, [...]
FibroGen to Report First Quarter 2018 Financial Results on Wednesday, May 9, 2018
02/05/2018
Conference Call and Audio Webcast Scheduled for 5:00 p.m. ET (2:00 p.m. PT) SAN FRANCISCO, May 02, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that [...]
Recro Pharma to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9, 2018
02/05/2018
Conference Call and Webcast Scheduled for Wednesday, May 9, 2018 at 8:00 a.m. ET MALVERN, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ: REPH ), a revenue generating specialty pharmaceutical company [...]
Amedisys Closes on Acquisition Expanding Personal Care to Tennessee
02/05/2018
BATON ROUGE, La., May 02, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home [...]
Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS
02/05/2018
Program currently available in the U.S. and select countries in Europe; initiating additional countries throughout 2018 CAMBRIDGE, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ) today [...]
miRagen Therapeutics to Report First Quarter 2018 Financial Results and Host Conference Call on May 9, 2018
02/05/2018
BOULDER, Colo., May 02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Pages